Northwest Biotherapeutics, Inc. (NWBO)
0.1537
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
Northwest Biotherapeutics Market Cap : 256.57M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 256.57M |
| October 01, 2026 | 254.40M |
| September 30, 2026 | 248.56M |
| September 29, 2026 | 249.56M |
| September 28, 2026 | 254.57M |
| September 25, 2026 | 267.09M |
| September 24, 2026 | 266.42M |
| September 23, 2026 | 266.50M |
| September 22, 2026 | 272.10M |
| September 21, 2026 | 278.77M |
| September 18, 2026 | 267.25M |
| September 17, 2026 | 276.27M |
| September 16, 2026 | 276.42M |
| September 15, 2026 | 287.29M |
| September 14, 2026 | 275.10M |
| September 11, 2026 | 281.94M |
| September 10, 2026 | 275.85M |
| September 09, 2026 | 282.81M |
| September 08, 2026 | 282.70M |
| September 04, 2026 | 283.20M |
| September 03, 2026 | 283.63M |
| September 02, 2026 | 282.78M |
| September 01, 2026 | 280.44M |
| August 31, 2026 | 284.07M |
| August 28, 2026 | 316.50M |
| Date | Value |
|---|---|
| August 27, 2026 | 299.04M |
| August 26, 2026 | 288.79M |
| August 25, 2026 | 290.29M |
| August 24, 2026 | 287.92M |
| August 21, 2026 | 283.11M |
| August 20, 2026 | 285.88M |
| August 19, 2026 | 296.38M |
| August 18, 2026 | 300.31M |
| August 17, 2026 | 304.65M |
| August 14, 2026 | 320.51M |
| August 13, 2026 | 317.17M |
| August 12, 2026 | 315.16M |
| August 11, 2026 | 305.31M |
| August 10, 2026 | 298.88M |
| August 07, 2026 | 295.03M |
| August 06, 2026 | 286.83M |
| August 05, 2026 | 263.53M |
| August 04, 2026 | 258.71M |
| August 03, 2026 | 256.30M |
| July 31, 2026 | 263.53M |
| July 30, 2026 | 265.14M |
| July 29, 2026 | 260.32M |
| July 28, 2026 | 275.41M |
| July 27, 2026 | 278.95M |
| July 24, 2026 | 275.87M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.434B |
| Alnylam Pharmaceuticals, Inc. | 29.38B |
| Savara, Inc. | 987.97M |
| Vericel Corp. | 2.055B |
| Biogen, Inc. | 32.48B |
Market Cap Related Metrics
| PS Ratio | 111.17 |
| Price | 0.1537 |
| Earnings Yield | -16.53% |